New Drug Approvals

Mobocertinib September 23, 2021 - (0)

Mobocertinib 1847461-43-1 MF C32H39N7O4MW 585.70 propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate TAK-788, AP32788, TAK788, UNII-39HBQ4A67L, AP-32788, 39HBQ4A67L US10227342, Example 10, MFCD32669806, NSC825519, s6813, TAK-788;AP32788, WHO 11183 NSC-825519, example 94 [WO2015195228A1], GTPL10468, BDBM368374, BCP31045, EX-A3392 US FDA APPROVED 9/15/2021, Exkivity, To treat locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutation Mobocertinib succinate Chemical Structure CAS No. : 2389149-74-8 Molecular Weight 703.78 Formula C₃₆H₄₅N₇O₈ Mobocertinib mesylateCAS# 2389149-85-1 (mesylate)C33H43N7O7SMolecular Weight: 681.809 CAS #: 2389149-85-1 […]
Verdiperstat September 22, 2021 - (0)
Vosoritide September 21, 2021 - (0)
MEVOCICLIB, SY 1365 September 20, 2021 - (0)
SY 5609 September 18, 2021 - (0)

Mobile Site | Full Site